NFKB1 and atherosclerosis: Furthermore, inhibiting upstream signalling cascades that promote adhesion molecule expression such as nuclear factor kappa light-chain enhancer of activated B cells (NFκB) specifically in ECs ameliorates atherosclerosis progression16.